Gentamicin Pharmacokinetics and Dosing in Neonates with Hypoxic Ischemic Encephalopathy Receiving Hypothermia

Overview

Journal Pharmacotherapy

Specialty Pharmacology

Date 2013 Apr 5

PMID 23553582

Citations 27

Authors

Adam Frymoyer

Lina Meng

Sonia L Bonifacio

Davide Verotta

B Joseph Guglielmo

Affiliations

Soon will be listed here.

Abstract

Study Objective: To evaluate the pharmacokinetics of gentamicin in neonates with hypoxic ischemic encephalopathy (HIE) receiving hypothermia and to identify an empiric gentamicin dosing strategy in this population that optimizes achievement of target peak and trough concentrations.

Design: Population pharmacokinetic study using retrospective medical record data.

Setting: Tertiary neonatal intensive care unit.

Patients: A total of 29 full-term neonates diagnosed with HIE treated with hypothermia who received gentamicin and underwent therapeutic drug monitoring

Measurement And Main Results: Patient demographics and gentamicin concentration data were retrospectively collected over a 2-year period. A population-based pharmacokinetic model was developed using nonlinear mixed-effects modeling (NONMEM). Using the developed model, Monte Carlo simulations were performed to evaluate the probability of achieving target peak (> 6 mg/L) and trough (< 2 mg/L) gentamicin concentrations for various potential dosing regimens. A one-compartment model best described the available gentamicin concentration data. Birthweight and serum creatinine significantly influenced gentamicin clearance. For the typical study neonate (birthweight 3.3 kg, serum creatinine 0.9 mg/dl), clearance was 0.034 L/hour/kg and volume was 0.52 L/kg. At a 24-hour dosing interval, Monte Carlo simulations predicted target gentamicin peak and trough concentrations could not be reliably achieved at any dose. At a 36-hour dosing interval, a dose of 4-5 mg/kg is predicted to achieve target gentamicin peak and trough concentrations in more than 90% of neonates.

Conclusions: Gentamicin clearance is decreased in neonates with HIE treated with hypothermia compared with previous reports in nonasphyxiated normothermic full-term neonates. A prolonged 36-hour dosing interval will be needed to achieve target gentamicin trough concentrations in this population. Further prospective evaluation of this dosing recommendation is needed.

Citing Articles

Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy.

Naik M, Warden E, Pittman R, Katakam L Paediatr Drugs. 2024; 27(1):85-90.

PMID: 39446309 DOI: 10.1007/s40272-024-00661-7.

Identifying Subgroups with Differential Responses to Amiodarone among Cardiac Arrest Patients with a Shockable Rhythm at Hospital Arrival using the Machine Learning Approach.

Emoto R, Nishikimi M, Kikutani K, Ishii J, Ohshimo S, Matsui S Rev Cardiovasc Med. 2024; 25(7):268.

PMID: 39139416 PMC: 11317310. DOI: 10.31083/j.rcm2507268.

Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives.

Zhang W, Zhang Q, Cao Z, Zheng L, Hu W Pharmaceutics. 2023; 15(12).

PMID: 38140105 PMC: 10747965. DOI: 10.3390/pharmaceutics15122765.

Continuous Fentanyl Infusion in Newborns with Hypoxic-Ischemic Encephalopathy Treated with Therapeutic Hypothermia: Background, Aims, and Study Protocol for Time-Concentration Profiles.

Lugli L, Garetti E, Goffredo B, Candia F, Crestani S, Spada C Biomedicines. 2023; 11(9).

PMID: 37760835 PMC: 10525845. DOI: 10.3390/biomedicines11092395.

Evaluation of Dosing Guidelines for Gentamicin in Neonates and Children.

Hollander E, Tuinen E, Scholvinck E, Bergman K, Bourgonje A, Gracchi V Antibiotics (Basel). 2023; 12(5).

PMID: 37237713 PMC: 10215193. DOI: 10.3390/antibiotics12050810.

References

Stolk L, Degraeuwe P, Nieman F, de Wolf M, de Boer A . Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit. 2002; 24(4):527-31. DOI: 10.1097/00007691-200208000-00011. View

Anderson B, Holford N . Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol. 2007; 48:303-32. DOI: 10.1146/annurev.pharmtox.48.113006.094708. View

Krawczeski C, Woo J, Wang Y, Bennett M, Ma Q, Devarajan P . Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr. 2011; 158(6):1009-1015.e1. DOI: 10.1016/j.jpeds.2010.12.057. View

Rastogi A, Agarwal G, Pyati S, Pildes R . Comparison of two gentamicin dosing schedules in very low birth weight infants. Pediatr Infect Dis J. 2002; 21(3):234-40. DOI: 10.1097/00006454-200203000-00014. View

Lanao J, Calvo M, Mesa J, Martin-Suarez A, Carbajosa M, Miguelez F . Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. J Antimicrob Chemother. 2004; 54(1):193-8. DOI: 10.1093/jac/dkh261. View

Touw D, Westerman E, Sprij A . Therapeutic drug monitoring of aminoglycosides in neonates. Clin Pharmacokinet. 2009; 48(2):71-88. DOI: 10.2165/00003088-200948020-00001. View

Satas S, Hoem N, Melby K, Porter H, Lindgren C, Whitelaw A . Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs. Biol Neonate. 2000; 77(1):50-7. DOI: 10.1159/000014195. View

Gluckman P, Wyatt J, Azzopardi D, Ballard R, Edwards A, Ferriero D . Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005; 365(9460):663-70. DOI: 10.1016/S0140-6736(05)17946-X. View

Izquierdo M, Lanao J, Cervero L, Jimenez N, Dominguez-Gil A . Population pharmacokinetics of gentamicin in premature infants. Ther Drug Monit. 1992; 14(3):177-83. DOI: 10.1097/00007691-199206000-00001. View

10.

Thomson A, Way S, Bryson S, McGovern E, Kelman A, Whiting B . Population pharmacokinetics of gentamicin in neonates. Dev Pharmacol Ther. 1988; 11(3):173-9. DOI: 10.1159/000457685. View

11.

Pacifici G . Clinical pharmacokinetics of aminoglycosides in the neonate: a review. Eur J Clin Pharmacol. 2008; 65(4):419-27. DOI: 10.1007/s00228-008-0599-y. View

12.

Weber W, Kewitz G, Rost K, Looby M, Nitz M, Harnisch L . Population kinetics of gentamicin in neonates. Eur J Clin Pharmacol. 1993; 44 Suppl 1:S23-5. DOI: 10.1007/BF01428387. View

13.

Clark R, Bloom B, Spitzer A, Gerstmann D . Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006; 117(6):1979-87. DOI: 10.1542/peds.2005-1707. View

14.

Roka A, Vasarhelyi B, Bodrogi E, Machay T, Szabo M . Changes in laboratory parameters indicating cell necrosis and organ dysfunction in asphyxiated neonates on moderate systemic hypothermia. Acta Paediatr. 2007; 96(8):1118-21. DOI: 10.1111/j.1651-2227.2007.00361.x. View

15.

Zanelli S, Buck M, Fairchild K . Physiologic and pharmacologic considerations for hypothermia therapy in neonates. J Perinatol. 2010; 31(6):377-86. PMC: 3552186. DOI: 10.1038/jp.2010.146. View

16.

Moore R, Smith C, Lietman P . Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med. 1984; 77(4):657-62. DOI: 10.1016/0002-9343(84)90358-9. View

17.

Azzopardi D, Strohm B, Edwards A, Dyet L, Halliday H, Juszczak E . Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009; 361(14):1349-58. DOI: 10.1056/NEJMoa0900854. View

18.

Askenazi D, Ambalavanan N, Goldstein S . Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?. Pediatr Nephrol. 2008; 24(2):265-74. PMC: 2755786. DOI: 10.1007/s00467-008-1060-2. View

19.

Bonifacio S, Glass H, VanderPluym J, Agrawal A, Xu D, Barkovich A . Perinatal events and early magnetic resonance imaging in therapeutic hypothermia. J Pediatr. 2010; 158(3):360-5. PMC: 3035732. DOI: 10.1016/j.jpeds.2010.09.003. View

20.

Shah P . Hypothermia: a systematic review and meta-analysis of clinical trials. Semin Fetal Neonatal Med. 2010; 15(5):238-46. DOI: 10.1016/j.siny.2010.02.003. View